Kiwa Bio-Tech Products Group (OTCMKTS:KWBT – Get Free Report) and Methanex (NASDAQ:MEOH – Get Free Report) are both basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.
Earnings & Valuation
This table compares Kiwa Bio-Tech Products Group and Methanex”s gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Kiwa Bio-Tech Products Group | N/A | N/A | N/A | N/A | N/A |
Methanex | $3.72 billion | 0.80 | $163.99 million | $3.39 | 11.35 |
Insider and Institutional Ownership
73.5% of Methanex shares are owned by institutional investors. 1.3% of Kiwa Bio-Tech Products Group shares are owned by company insiders. Comparatively, 1.0% of Methanex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Analyst Recommendations
This is a summary of current ratings and target prices for Kiwa Bio-Tech Products Group and Methanex, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Kiwa Bio-Tech Products Group | 0 | 0 | 0 | 0 | 0.00 |
Methanex | 0 | 2 | 5 | 1 | 2.88 |
Methanex has a consensus target price of $44.88, suggesting a potential upside of 16.62%. Given Methanex’s stronger consensus rating and higher probable upside, analysts plainly believe Methanex is more favorable than Kiwa Bio-Tech Products Group.
Profitability
This table compares Kiwa Bio-Tech Products Group and Methanex’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Kiwa Bio-Tech Products Group | N/A | N/A | N/A |
Methanex | 7.02% | 12.61% | 4.66% |
Summary
Methanex beats Kiwa Bio-Tech Products Group on 9 of the 10 factors compared between the two stocks.
About Kiwa Bio-Tech Products Group
Kiwa Bio-Tech Products Group Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers. The company has a strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center; China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning; and Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.
About Methanex
Methanex Corporation produces and supplies methanol in China, Europe, the United States, South America, South Korea, Canada, and Asia. The company also purchases methanol produced by others under methanol offtake contracts and on the spot market. In addition, it owns and leases storage and terminal facilities. The company owns and manages a fleet of approximately 30 ocean-going vessels. It serves chemical and petrochemical producers. Methanex Corporation was incorporated in 1968 and is headquartered in Vancouver, Canada.
Receive News & Ratings for Kiwa Bio-Tech Products Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kiwa Bio-Tech Products Group and related companies with MarketBeat.com's FREE daily email newsletter.